Go to main content

The prostate cancer dilemma [electronic resource] : selecting patients for active surveillance, focal ablation and definitive therapy / Nelson N. Stone, E. David Crawford, editors.

Stone, Nelson N., editor.; Crawford, E. David, editor.
2016
RC280.P7
Available Online
Formats
Format
BibTeX
MARCXML
TextMARC
MARC
DublinCore
EndNote
NLM
RefWorks
RIS
Add to Basket
Cite
Citation

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
The prostate cancer dilemma [electronic resource] : selecting patients for active surveillance, focal ablation and definitive therapy / Nelson N. Stone, E. David Crawford, editors.
ISBN
9783319214856 (electronic book)
3319214853 (electronic book)
9783319214849
3319214845
DOI
https://doi.org/10.1007/978-3-319-21485-6
Published
Cham : Springer, 2016.
Language
English
Description
1 online resource.
Item Number
10.1007/978-3-319-21485-6 doi
Call Number
RC280.P7
Dewey Decimal Classification
616.99/463
Summary
This comprehensive text provides a complete description of the newest technologies to diagnose and manage the most common prostate cancer diagnosed today: low risk disease. The book reviews new data about genetic markers, transperineal mapping biopsy and mpMRI, how to apply each of these technologies in patients with elevated PSA, when a prior prostate biopsy performed by the standard TRUS method is negative, and, in cases where low risk disease is already diagnosed, how to differentiate those men who might harbor more aggressive disease from those who do not. Over 75% of newly diagnosed prostate cancer meets the criteria for low risk disease which has created a dilemma for both patients and clinicians because of the inaccuracy of the standard TRUS biopsy method. Active surveillance programs have been initiated and are reviewed. How the new technologies impact surveillance programs are addressed. Clinical stage designation is updated and a new intra-prostatic staging system is discussed. Prostate biopsy techniques utilizing transrectal ultrasound, transperineal mapping, elastography and mpMRI are compared. Finally, utilization of these new technologies in the application of focal therapy is reviewed. The Prostate Cancer Dilemma will serve as a valuable resource for clinicians, surgeons and researchers with an interest in early prostate cancer. Chapters are written by experts in their fields and include the most up-to-date scientific and clinical information as well as links to procedural video content.
Bibliography, etc. Note
Includes bibliographical references and index.
Access Note
Access limited to authorized users.
Source of Description
Online resource; title from PDF title page (viewed October 29, 2015)
Added Author
Stone, Nelson N., editor.
Crawford, E. David, editor.
Available in Other Form
Print version: 9783319214849
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
Part One: Diagnosis
History of PSA, from Detection to Over Diagnosis
Pathology of Prostate Cancer: What has Changed in the Last 30 years?- Clinical Risk Prediction Tools for Prostate Cancer: TMN to CAPRA-Should Risk be Re-defined?- TRUS Biopsy: Is There Still a Role?- Transperineal Biopsy Technique
3D Biopsy: A New Method to Diagnose Prostate Cancer
Elastography: Can it Improve Prostate Biopsy Results?- Multi parametric MRI of the Prostate as a Tool for Prostate Cancer Detection
Genomic Markers
Part Two: Treatment
Current Status of Clinical Trials in Active Surveillance
Focused targeted Therapy in Prostate Cancer
Technologies and Methods in Primary Ablation with Focal Therapy
Multi parametric MRI (mpMRI)-Guided Focal Therapy
Conclusions.

Browse Subjects

Show more subjects...

Statistics

from
to
Export